BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 9437382)

  • 1. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia.
    Heard SO; Wagle M; Vijayakumar E; McLean S; Brueggemann A; Napolitano LM; Edwards LP; O'Connell FM; Puyana JC; Doern GV
    Arch Intern Med; 1998 Jan; 158(1):81-7. PubMed ID: 9437382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients.
    Carrasco MN; Bueno A; de las Cuevas C; Jimenez S; Salinas I; Sartorius A; Recio T; Generelo M; Ruiz-Ocaña F
    Intensive Care Med; 2004 Apr; 30(4):633-8. PubMed ID: 14722639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.
    Maki DG; Stolz SM; Wheeler S; Mermel LA
    Ann Intern Med; 1997 Aug; 127(4):257-66. PubMed ID: 9265424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial.
    Brun-Buisson C; Doyon F; Sollet JP; Cochard JF; Cohen Y; Nitenberg G
    Intensive Care Med; 2004 May; 30(5):837-43. PubMed ID: 15060765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
    Darouiche RO; Raad II; Heard SO; Thornby JI; Wenker OC; Gabrielli A; Berg J; Khardori N; Hanna H; Hachem R; Harris RL; Mayhall G
    N Engl J Med; 1999 Jan; 340(1):1-8. PubMed ID: 9878638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial.
    Rupp ME; Lisco SJ; Lipsett PA; Perl TM; Keating K; Civetta JM; Mermel LA; Lee D; Dellinger EP; Donahoe M; Giles D; Pfaller MA; Maki DG; Sherertz R
    Ann Intern Med; 2005 Oct; 143(8):570-80. PubMed ID: 16230723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy.
    Lorente L; Lecuona M; Jiménez A; Cabrera J; Santacreu R; Lorenzo L; Raja L; Mora ML
    Am J Infect Control; 2016 Dec; 44(12):1526-1529. PubMed ID: 27378009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreasing catheter-related infection and hospital costs by continuous quality improvement.
    Civetta JM; Hudson-Civetta J; Ball S
    Crit Care Med; 1996 Oct; 24(10):1660-5. PubMed ID: 8874302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of silver-coating central venous catheters in reducing bacterial colonization.
    Bach A; Eberhardt H; Frick A; Schmidt H; Böttiger BW; Martin E
    Crit Care Med; 1999 Mar; 27(3):515-21. PubMed ID: 10199530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients--a double-blind, randomised, prospective, controlled trial.
    Ostendorf T; Meinhold A; Harter C; Salwender H; Egerer G; Geiss HK; Ho AD; Goldschmidt H
    Support Care Cancer; 2005 Dec; 13(12):993-1000. PubMed ID: 15834740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of coagulase-negative staphylococcal nosocomial bloodstream isolates to the chlorhexidine/silver sulfadiazine-impregnated central venous catheter.
    Rosato AE; Tallent SM; Edmond MB; Bearman GM
    Am J Infect Control; 2004 Dec; 32(8):486-8. PubMed ID: 15573055
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
    Schuerer DJ; Zack JE; Thomas J; Borecki IB; Sona CS; Schallom ME; Venker M; Nemeth JL; Ward MR; Verjan L; Warren DK; Fraser VJ; Mazuski JE; Boyle WA; Buchman TG; Coopersmith CM
    Surg Infect (Larchmt); 2007 Aug; 8(4):445-54. PubMed ID: 17883361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients.
    Sheng WH; Ko WJ; Wang JT; Chang SC; Hsueh PR; Luh KT
    Diagn Microbiol Infect Dis; 2000 Sep; 38(1):1-5. PubMed ID: 11025176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
    Bonne S; Mazuski JE; Sona C; Schallom M; Boyle W; Buchman TG; Bochicchio GV; Coopersmith CM; Schuerer DJ
    J Am Coll Surg; 2015 Sep; 221(3):739-47. PubMed ID: 26199017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of prolonging the use of central venous catheters: a prospective analysis of the effects of using antiseptic-bonded catheters with daily site care.
    Norwood S; Wilkins HE; Vallina VL; Fernandez LG; McLarty JW
    Crit Care Med; 2000 May; 28(5):1376-82. PubMed ID: 10834681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis.
    Ciresi DL; Albrecht RM; Volkers PA; Scholten DJ
    Am Surg; 1996 Aug; 62(8):641-6. PubMed ID: 8712561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit.
    Osma S; Kahveci SF; Kaya FN; Akalin H; Ozakin C; Yilmaz E; Kutlay O
    J Hosp Infect; 2006 Feb; 62(2):156-62. PubMed ID: 16307824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised study.
    Camargo LF; Marra AR; Büchele GL; Sogayar AM; Cal RG; de Sousa JM; Silva E; Knobel E; Edmond MB
    J Hosp Infect; 2009 Jul; 72(3):227-33. PubMed ID: 19443078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial.
    Logghe C; Van Ossel C; D'Hoore W; Ezzedine H; Wauters G; Haxhe JJ
    J Hosp Infect; 1997 Oct; 37(2):145-56. PubMed ID: 9364263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
    Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
    Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.